NASDAQ: HSIC

Henry Schein (HSIC) Stock Analysis & Forecast

Nov 13 close

$86.22+0.08 (+0.1%)

Gekko Brief

AI summaryNov 9 close

Henry Schein draws attention this week on an analyst upgrade to Buy and a round of coverage framing it as a growth and value candidate, including a comparison against Merit Medical on valuation grounds. The company also confirmed it will present at the Jefferies Healthcare Conference in London on 17 November and in New York on 1 December, keeping investor attention on upcoming appearances rather than new operating news.

Shares closed at $88.41, up 2.7% on the day, sitting above both the 50-day average of $86.11 and the 200-day average of $81.29, with the 50-day above the 200-day. The stock trades in the Neutral zone of the GekkoIndex, with a reading of 52.3 that has edged down 1.7 over five days. Price sits 6.3% above Gekko Fair Value of $83.2, and the one-year return stands at 26.2% versus a six-month gain of 28.1%.

The next earnings date falls on 23 February 2027, 105 days out, placing it outside a typical 20-trading-day holding window. No insider, Congress, or unusual options activity appears in the current windows, while one billionaire holder and one trailblazer holder are recorded among current positions. Seasonality from this point in the calendar has averaged a 4.1% gain over the next 20 trading days across 5 years, rising in 4 of them. Consensus among 10 firms stands at 6 buy, 3 hold, 1 sell, with a target of $96.93.

Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.

Henry Schein price vs fair value

$86.22$80.73Nov ’25May ’26Nov ’26
Close $86.22200-day averageGekko Fair Value $80.73

Henry Schein quick facts

Market cap
$9.53B
P/E ratio
23.6
Forward P/E
14.7
EPS, TTM
$3.65
Revenue, TTM
$13.73B
Profit margin
3.1%
Dividend yield
—
Beta
0.86
Volume
2.18M avg 1.64M
1-year return
+18.4%
Typical daily move
±3.4%
Typical 20-day move
±4.6%
50-day average
$85.91
200-day average
$81.52
Next earnings
Feb 23
Shares outstanding
110.5M
52-week range
$68.70$92.18

Henry Schein swing-trade checklist

Henry Schein scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

3 supportive1 mixed1 headwind

  • Trendsupportive

    Above 50 and 200-day

    Close $86.22 is above the 50-day ($85.91) and 200-day ($81.52) averages, and the 50-day is above the 200-day.

    See the chart
  • GekkoIndexmixed

    57.2, Neutral

    Reading 57.2 is in the Neutral zone.

    See the GekkoIndex
  • Fair valueheadwind

    6.8% above

    Price is 6.8% above Gekko Fair Value (more than 5% above).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings risksupportive

    Reports in 100 days

    Next report Feb 23, 2027, 100 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalitysupportive

    +6.3% on average

    From this point in the calendar, the next 20 trading days averaged +6.3% over 5 years, rising in 4 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

Henry Schein stock chart and price history

Henry Schein closed at $86.22 on Nov 13, 2026, +18.4% over the past year, inside a 52-week range of $68.70 to $92.18.

Close50-day average200-day averageVolume
Henry Schein share price, past year, with 50-day and 200-day moving averages and volume$70$75$80$90DecJan 2026FebMarAprMayJunJulAugSepOctNov86.22

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
−0.9%
3 months
−3.7%
6 months
+18.6%
1 year
+18.4%
The full HSIC chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open HSIC in Gekko

Follow Henry Schein through every session

Put HSIC on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track HSIC in GekkoFree for 7 days. No credit card required.

About Henry Schein

Henry Schein provides a wide range of healthcare products and services to customers that include dental practices and labs, physician offices, government agencies, and other institutional and alternative care providers worldwide. It has built recognition around supplying dental items like infection control materials, impression materials, composites, anesthetics, and artificial teeth, plus tools such as handpieces, chairs, delivery systems, X-ray machines, and digital restoration equipment, along with protective gear and repair services for that equipment. It also moves a large volume of medical supplies, covering branded and generic drugs, vaccines, surgical tools, diagnostic kits, infection prevention items, imaging equipment, and nutritional products.

Its business is split into two segments. One, Health Care Distribution, centers on getting these dental and medical goods to customers along with repair work. The other, Technology and Value-Added Services, offers practice management software built for dental and medical providers, plus support like non-recourse financing, electronic tools, network and technology infrastructure help, hardware servicing, training programs, and consulting.

Henry Schein traces back to 1932 and runs its headquarters out of Melville, New York. Shares trade on the NASDAQ under the ticker HSIC.

Listed
NASDAQ
Sector
Distribution services
Industry
Medical distributors
Website
henryschein.com

Henry Schein GekkoIndex: the smart money zone

Henry Schein’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 57.2, in the Neutral zone, up 2.6 points over five sessions.

010057.2Neutral

Up 2.6 points over five sessions.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying28+2.4%+2.0%+4.1%+8.7%
Accumulation239+0.6%+1.3%+2.7%+4.6%
Neutral (current zone)407−0.2%−0.3%−0.7%−0.6%
Distribution27−0.2%−0.7%−2.1%−2.1%
Selling1Too few readings yet

Average HSIC share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.

Neutral zone: No clear directional signal. About the five zones →

See every daily GekkoIndex reading plotted over the HSIC price, zone by zone.Track HSIC in Gekko

Is Henry Schein stock overvalued? Gekko Fair Value

Henry Schein trades 6.8% above Gekko Fair Value of $80.73, so the shares are overvalued on Gekko’s estimate.

Gekko’s own estimate of what Henry Schein shares are worth, recalculated every trading day.

$80.73

Gekko Fair Value, Nov 14, 2026

6.8% Overvalued

At the end of Aug 2026 the price was 3.9% above the estimate.

Gekko Fair ValueShare price, month end
$81$86Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open HSIC in Gekko

Henry Schein insider and Congress trading

No open-market insider purchases were filed for Henry Schein, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for HSIC in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every HSIC insider filing, plotted on the chart in Gekko.Open HSIC in Gekko

Congress trades last 90 days

No trades in HSIC were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for HSIC, plotted on the chart in Gekko.Open HSIC in Gekko

Buybacks

Henry Schein has been buying back its own shares.

Bought back, quarter ended Sep 26, 2026
$125.0M
As a share of market cap
1.31%
Trailing four quarters
$650.0M

From company filings.

Hedge funds and billionaires quarter ended Jun 30

2of the funds Gekko tracks hold HSIC.

2added0opened0trimmed0sold out
Which funds are on each side, name by name.Unlock in Gekko

Henry Schein earnings: next date and track record

Henry Schein reports on Feb 23, 2027 (100 days away), and beat the EPS estimate in 6 of its last 8 reports.

6 of 8reports beat the EPS estimate
±5%average move across the report
4 of 8reports followed by a gain

Share-price move across each report

+6.2%May ’24−5.4%Aug ’24−3.2%Nov ’24−6.6%Feb ’25+1.4%May ’25−5.3%Aug ’25+11.4%Nov ’25+0.5%Mar ’26

Last earnings call, Mar 31, 2026 AI summary

What they said
HSIC reported fourth quarter 2025 results with continuing sales momentum achieving the highest quarterly sales. The company is undergoing a leadership transition with Fred Lowry becoming CEO designate, joining from Thermo Fisher Scientific where he spent 20 years. Management emphasized successful transformation management and significant growth opportunities ahead.
Guidance
No specific forward-looking guidance or revenue/earnings targets were provided in this excerpt. Management expressed confidence in accelerating strategy implementation under new leadership.
ReportedEPSSurpriseRevenueSurpriseMove
Mar 31, 2026$1.32
est $1.22
+8.4%$3.44B
est $3.35B
+2.7%+0.5%
Nov 4, 2025$1.38
est $1.27
+8.7%$3.34B
est $3.34B
−0.2%+11.4%
Aug 5, 2025$1.10
est $1.18
−6.8%$3.24B
est $3.28B
−1.1%−5.3%
May 5, 2025$1.15
est $1.11
+3.6%$3.17B
est $3.22B
−1.5%+1.4%
Feb 25, 2025$1.19
est $1.21
−1.6%$3.19B
est $3.29B
−3.1%−6.6%
Nov 5, 2024$1.22
est $1.17
+4.3%$3.17B
est $3.36B
−5.6%−3.2%
Aug 6, 2024$1.23
est $1.22
+0.8%$3.14B
est $3.28B
−4.4%−5.4%
May 7, 2024$1.10
est $1.01
+8.9%$3.17B
est $3.21B
−1.0%+6.2%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Henry Schein stock forecast and analyst price targets

Analysts’ average 12-month price target for Henry Schein is $96.60, +12.0% from the last close, from 10 firms rating the stock in the last 90 days.

$96.60consensus 12-month target, +12.0% from the last close
Low $64High $110
Buy6
Hold3
Sell1

Each firm’s latest rating in the last 90 days: 10 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Nov 4BarclaysBuy, maintained$100+16.0%
Nov 4BMO CapitalHold, maintained$85−1.4%
Nov 4BarringtonBuy, maintained$104+20.6%
Nov 4Piper SandlerBuy, maintained$104+20.6%
Nov 4UBSHold, maintained$95+10.2%
−0.7%average 20-day move after past Neutral readings
+6.3%average move over the next 20 trading days in the last 5 years
±3.4%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Henry Schein seasonality: the next 20 trading days

Over the next 20 trading days from Nov 14, Henry Schein averaged +6.3% across the last 5 years, rising in 4 of them.

Next 20 trading days, by year

−5.0%2021+7.0%2022+7.4%2023+15.1%2024+8.3%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days+2.1%4 of 5
Next 10 trading days+1.6%3 of 5
Next 15 trading days+2.0%4 of 5
Next 20 trading days+6.3%4 of 5
Next 30 trading days+4.6%4 of 5

For scale, HSIC’s typical 20-trading-day move in either direction is about 4.6%.

Henry Schein market cap and key statistics

Henry Schein’s market cap is $9.53B, with a P/E ratio of 23.6 and revenue of $13.73B over the last twelve months.

Valuation

Market cap
$9.53B
P/E ratio
23.6
Forward P/E
14.7
EPS, TTM
$3.65
Gekko Fair Value
$80.73

Trading

Volume
2.18M
Avg volume, 20 days
1.64M
52-week high
$92.18
52-week low
$68.70
Shares outstanding
110.5M

Financials

Revenue, TTM
$13.73B
Profit margin
3.1%
Return on equity
9.2%
Quarterly earnings growth, YoY
+26.2%

Risk and income

Beta
0.86
Typical daily move
±3.4%
Typical 20-day move
±4.6%

Henry Schein stock news this week

Coverage of Henry Schein this week reads neutral: 1 positive, 3 neutral and 0 negative headlines.

News sentiment neutral

Henry Schein peers

Henry Schein’s 3 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
MCKMcKesson+1.4%Distribution2.2% above
CORCencora+2.3%Neutral34.2% below
CAHCardinal Health+0.4%Distribution31.7% below

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Distribution services

Henry Schein stock FAQ

What is Henry Schein’s market cap?

Henry Schein’s market cap is $9.53B at the Nov 13, 2026 close of $86.22, with 110.5M shares outstanding. The shares trade on a P/E ratio of 23.6.

What is the Henry Schein stock forecast?

The consensus analyst 12-month price target for Henry Schein is $96.60, +12.0% from the last close. Of the 10 firms that rated the stock in the last 90 days, 6 rate it a buy, 3 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.

Is Henry Schein stock overvalued or undervalued?

On Gekko’s estimate Henry Schein is overvalued: the Nov 13, 2026 close of $86.22 is 6.8% above Gekko Fair Value of $80.73. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Henry Schein report earnings next?

Henry Schein is expected to report on Feb 23, 2027 (100 days away). Analysts expect earnings of $1.40 per share on revenue of $3.55B. Henry Schein beat the earnings estimate in 6 of its last 8 reports, moving 5% on average across the report.

What is Henry Schein’s 52-week high and low?

Henry Schein’s 52-week high is $92.18 and its 52-week low is $68.70; it closed at $86.22 on Nov 13, 2026, +18.4% over the past year. Over the last five years the shares peaked at $92.68 on Apr 14, 2022.

Is Henry Schein stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, earnings risk and seasonality), 1 as mixed (gekkoindex) and 1 as a headwind (fair value). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Henry Schein the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.